Your browser doesn't support javascript.
loading
First Evidence of Activity of Enfortumab Vedotin on Brain Metastases in Urothelial Cancer Patients.
Vulsteke, Christof; De Cocker, Laurens; Gómez de Liaño, Alfonso; Montesdeoca, Cristina; De Meulenaere, Astrid; Croes, Lieselot; Delombaerde, Danielle; Szabados, Bernadett; Powles, Thomas.
Affiliation
  • Vulsteke C; Integrated Cancer Center Ghent, Department of Medical Oncology, AZ Maria Middelares, 9000 Ghent, Belgium.
  • De Cocker L; The Center for Oncological Research, University of Antwerp, 2650 Edegem, Belgium.
  • Gómez de Liaño A; Integrated Cancer Center Ghent, Department of Radiology, AZ Maria Middelares, 9000 Ghent, Belgium.
  • Montesdeoca C; Medical Oncology Department, CHU Insular-Materno Infantil, 35010 Las Palmas, Spain.
  • De Meulenaere A; Medical Oncology Department, CHU Insular-Materno Infantil, 35010 Las Palmas, Spain.
  • Croes L; Integrated Cancer Center Ghent, Department of Medical Oncology, AZ Maria Middelares, 9000 Ghent, Belgium.
  • Delombaerde D; Integrated Cancer Center Ghent, Department of Medical Oncology, AZ Maria Middelares, 9000 Ghent, Belgium.
  • Szabados B; The Center for Oncological Research, University of Antwerp, 2650 Edegem, Belgium.
  • Powles T; Integrated Cancer Center Ghent, Department of Medical Oncology, AZ Maria Middelares, 9000 Ghent, Belgium.
Pharmaceuticals (Basel) ; 16(3)2023 Mar 01.
Article in En | MEDLINE | ID: mdl-36986475
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Pharmaceuticals (Basel) Year: 2023 Document type: Article Affiliation country: Belgium Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Pharmaceuticals (Basel) Year: 2023 Document type: Article Affiliation country: Belgium Country of publication: Switzerland